Harris Group
Harris Group is a venture capital firm based in Seattle, United States, focused on startups in Fintech. This profile covers its focus and how founders can get in front of it in 2026.
Harris group is a non-diversified management investment company operating as a business development.
- Investment focus
- Fintech
- Location
- Seattle, United States
- Team size
- 251-500
How to pitch Harris Group
The founders who hear back from Harris Group lead with traction and a clear ask that matches its stage, not a generic mass email. Build a targeted, verified list, write a personalized note, and track who opens it, all in one place.
Connect with Harris Group
About this profile
This profile is part of Round Funded, an investor database and outreach platform for founders. It covers 60,000+ active VCs, angels, family offices and accelerators with verified contacts, lets you send pitches from your own Gmail, and includes a free Data Room for your raise. How this data is built.
Cite this page
Round Funded. "Harris Group." Round Funded investor database, updated October 19, 2026.
Stable URL, it will not change: https://www.roundfunded.com/en/vc/harris-group
Frequently Asked Questions
What does Harris Group invest in?
Harris Group focuses on Fintech. Match your sector and stage before reaching out, then find similar active investors on Round Funded.
Where is Harris Group based?
Harris Group is based in Seattle, United States. You can reach out from anywhere with a pitch that matches its focus.
How do I contact Harris Group?
Unlock a verified email for Harris Group and reach out with a personalized pitch on Round Funded. We show only deliverable contacts, so your outreach does not bounce.
What is Round Funded?
Round Funded is an investor database and outreach platform for startup founders. It lists 60,000+ active investors with verified contacts, filtered to recent investment activity, and lets founders send personalized pitches from their own Gmail, track replies, and share a free Data Room. Round+ starts at $99 per month with a 3-day trial.